Cargando…

Therapeutic Effect of Platelet-Rich Plasma Improves Bladder Overactivity in the Pathogenesis of Ketamine-Induced Ulcerative Cystitis in a Rat Model

The present study attempted to elucidate whether intravesical instillation of platelet-rich plasma (PRP) could decrease bladder inflammation and ameliorate bladder hyperactivity in ketamine ulcerative cystitis (KIC) rat model. Female Sprague Dawley (S-D) rats were randomly divided into control group...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chueh, Kuang-Shun, Huang, Kuan-Hua, Lu, Jian-He, Juan, Tai-Jui, Chuang, Shu-Mien, Lin, Rong-Jyh, Lee, Yi-Chen, Long, Cheng-Yu, Shen, Mei-Chen, Sun, Ting-Wei, Juan, Yung-Shun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9147926/ https://www.ncbi.nlm.nih.gov/pubmed/35628581 http://dx.doi.org/10.3390/ijms23105771

Ejemplares similares

Autophagy Alters Bladder Angiogenesis and Improves Bladder Hyperactivity in the Pathogenesis of Ketamine-Induced Cystitis in a Rat Model
por: Lu, Jian-He, et al.
Publicado: (2021)

Effects of Therapeutic Platelet-Rich Plasma on Overactive Bladder via Modulating Hyaluronan Synthesis in Ovariectomized Rat
por: Lu, Jian-He, et al.
Publicado: (2023)

Urinary Biomarkers in Interstitial Cystitis/Bladder Pain Syndrome and Its Impact on Therapeutic Outcome
por: Lin, Hung-Yu, et al.
Publicado: (2021)

The Molecular Mechanism and Therapeutic Application of Autophagy for Urological Disease
por: Chueh, Kuang-Shun, et al.
Publicado: (2023)

Low-Intensity Extracorporeal Shock Wave Therapy Promotes Bladder Regeneration and Improves Overactive Bladder Induced by Ovarian Hormone Deficiency from Rat Animal Model to Human Clinical Trial
por: Lin, Kun-Ling, et al.
Publicado: (2021)

Epigenetic regulation of COX-2 expression by DNA hypomethylation via NF-κB activation in ketamine-induced ulcerative cystitis
por: Chuang, Shu-Mien, et al.
Publicado: (2019)

Low-Intensity Extracorporeal Shock Wave Therapy Ameliorates the Overactive Bladder: A Prospective Pilot Study
por: Lee, Yung-Chin, et al.
Publicado: (2020)

Low Intensity Extracorporeal Shock Wave Therapy as a Potential Treatment for Overactive Bladder Syndrome
por: Lu, Jian-He, et al.
Publicado: (2021)

Bladder Hyperactivity Induced by Oxidative Stress and Bladder Ischemia: A Review of Treatment Strategies with Antioxidants
por: Wu, Yi-Hsuan, et al.
Publicado: (2021)

Molecular Pathophysiology and Potential Therapeutic Strategies of Ketamine-Related Cystitis
por: Chen, Chin-Li, et al.
Publicado: (2022)

Epigallocatechin-3-gallate alleviates bladder overactivity in a rat model with metabolic syndrome and ovarian hormone deficiency through mitochondria apoptosis pathways
por: Lee, Yi-Lun, et al.
Publicado: (2018)

Acquired Methemoglobinemia in a Ketamine-induced Ulcerative Cystitis Patient: A Case Report
por: Kozik, Spencer, et al.
Publicado: (2022)

Re: Gaseous bladder tamponade secondary to emphysematous cystitis
por: Chen, Yu-Chen, et al.
Publicado: (2018)

The Immunomodulatory Imbalance in Patients with Ketamine Cystitis
por: Fan, Gang-Yi, et al.
Publicado: (2017)

Ketamine Cystitis: An Underrecognized Cause of Dysuria
por: Kutscher, Eric, et al.
Publicado: (2022)

Therapeutic effects of Low intensity extracorporeal low energy shock wave therapy (LiESWT) on stress urinary incontinence
por: Long, Cheng-Yu, et al.
Publicado: (2020)

The Overlap of Interstitial Cystitis/Painful Bladder Syndrome and Overactive Bladder
por: Chung, Maurice K., et al.
Publicado: (2010)

Clinical significance of interleukin-6 and inducible nitric oxide synthase in ketamine-induced cystitis
por: Huang, Chi-Jung, et al.
Publicado: (2018)

Low Intensity Extracorporeal Shock Wave Therapy as a Novel Treatment for Stress Urinary Incontinence: A Randomized-Controlled Clinical Study
por: Lin, Kun-Ling, et al.
Publicado: (2021)

Nerve hyperplasia: a unique feature of ketamine cystitis
por: Baker, Simon C, et al.
Publicado: (2013)

Pathophysiology, clinical presentation, and management of ketamine-induced cystitis
por: Jhang, Jia-Fong, et al.
Publicado: (2023)

Mechanisms Underlying Overactive Bladder and Interstitial Cystitis/Painful Bladder Syndrome
por: Grundy, Luke, et al.
Publicado: (2018)

Clinical application of intravesical botulinum toxin type A for overactive bladder and interstitial cystitis
por: Chen, Jing-Liang, et al.
Publicado: (2020)

Primary renal angiosarcoma mimicking urothelial carcinoma – A case report and literature reviews
por: Chang, Che-Wei, et al.
Publicado: (2020)

Extracellular vesicles enhance oxidative stress through P38/NF‐kB pathway in ketamine‐induced ulcerative cystitis
por: Xi, Xiao jian, et al.
Publicado: (2020)

Histopathological assessment of inflammation and expression of inflammatory markers in patients with ketamine-induced cystitis
por: LIN, HSIN-CHUNG, et al.
Publicado: (2015)

Changes to the bladder epithelial barrier are associated with ketamine-induced cystitis
por: Duan, Qixin, et al.
Publicado: (2017)

Comparison of bladder autoaugmentation by transurethral vesicomyotomy and hydrodistention for ketamine cystitis
por: Tan, Shuo, et al.
Publicado: (2021)

Intravesical Liposome and Antisense Treatment for Detrusor Overactivity and Interstitial Cystitis/Painful Bladder Syndrome
por: Tyagi, Pradeep, et al.
Publicado: (2014)

Protective effect of ketamine against hemorrhagic cystitis in rats receiving ifosfamide
por: Ozguven, Ali A., et al.
Publicado: (2014)

Urine biomarkers in ESSIC type 2 interstitial cystitis/bladder pain syndrome and overactive bladder with developing a novel diagnostic algorithm
por: Jiang, Yuan-Hong, et al.
Publicado: (2021)

Interstitial Cystitis Can Be Improved With Intravesical Instillation of Platelet-Rich Plasma
por: Hardy, Timothy J
Publicado: (2022)

Platelet-Rich Plasma Ameliorates Cyclophosphamide-Induced Acute Interstitial Cystitis/Painful Bladder Syndrome in a Rat Model
por: Chen, Yung-Hsiang, et al.
Publicado: (2020)

Overactive bladder with urodynamic study-induced bladder pain: An overactive bladder subtype with symptoms similar to those of interstitial cystitis/painful bladder syndrome
por: Mu, Hsueh-Yu, et al.
Publicado: (2023)

Repeated intravesical injections of platelet-rich plasma improve symptoms and alter urinary functional proteins in patients with refractory interstitial cystitis
por: Jiang, Yuan-Hong, et al.
Publicado: (2020)

Crucial Role of TRPC1 and TRPC4 in Cystitis-Induced Neuronal Sprouting and Bladder Overactivity
por: Boudes, Mathieu, et al.
Publicado: (2013)

von Brunn's Nests and Follicular Cystitis Following Intradetrusor OnabotulinumtoxinA Injections for Overactive Bladder
por: Nekkanti, Silpa, et al.
Publicado: (2017)

The clinical application of intravesical botulinum toxin A injection in patients with overactive bladder and interstitial cystitis
por: Jiang, Yuan-Hong, et al.
Publicado: (2022)

Cystitis due to the use of ketamine as a recreational drug: a case report
por: Colebunders, Britt, et al.
Publicado: (2008)

Abnormal Sensory Protein Expression and Urothelial Dysfunction in Ketamine-Related Cystitis in Humans
por: Tsai, Yao Chou, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_86e5bq3dvfqb4sfo4b07ejuusa